APA

Hou X., Chen S., Zhang Y., Sha W., Yu X., Elsawah H., Afifi A. F., El-Khayat H. R., Nouh A., Hassan M. F., Fatah A. A., Rucker Joerg I., Sánchez Núñez J. M., Osthoff Rueda R., Jurkowska G., Walczak M., Malecka-Panas E., Linke K., Hartleb M. & Janssen-van Solingen G. (20150921). Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study in Poland, Egypt, Mexico and China. : Clinical drug investigation.

Chicago

Hou Xiaohua, Chen Shengliang, Zhang Yali, Sha Weihong, Yu Xiaofeng, Elsawah Hesham, Afifi Afifi Fahmy, El-Khayat Hisham Raafat, Nouh Alaa, Hassan Mohamed Fathalla, Fatah Ayman Abdel, Rucker Joerg Isabel, Sánchez Núñez Juan Manuel, Osthoff Rueda Rodolfo, Jurkowska Grazyna, Walczak Michal, Malecka-Panas Ewa, Linke Krzysztof, Hartleb Marek and Janssen-van Solingen Gwendolyn. 20150921. Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study in Poland, Egypt, Mexico and China. : Clinical drug investigation.

Harvard

Hou X., Chen S., Zhang Y., Sha W., Yu X., Elsawah H., Afifi A. F., El-Khayat H. R., Nouh A., Hassan M. F., Fatah A. A., Rucker Joerg I., Sánchez Núñez J. M., Osthoff Rueda R., Jurkowska G., Walczak M., Malecka-Panas E., Linke K., Hartleb M. and Janssen-van Solingen G. (20150921). Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study in Poland, Egypt, Mexico and China. : Clinical drug investigation.

MLA

Hou Xiaohua, Chen Shengliang, Zhang Yali, Sha Weihong, Yu Xiaofeng, Elsawah Hesham, Afifi Afifi Fahmy, El-Khayat Hisham Raafat, Nouh Alaa, Hassan Mohamed Fathalla, Fatah Ayman Abdel, Rucker Joerg Isabel, Sánchez Núñez Juan Manuel, Osthoff Rueda Rodolfo, Jurkowska Grazyna, Walczak Michal, Malecka-Panas Ewa, Linke Krzysztof, Hartleb Marek and Janssen-van Solingen Gwendolyn. Quality of life in patients with Irritable Bowel Syndrome (IBS), assessed using the IBS-Quality of Life (IBS-QOL) measure after 4 and 8 weeks of treatment with mebeverine hydrochloride or pinaverium bromide: results of an international prospective observational cohort study in Poland, Egypt, Mexico and China. : Clinical drug investigation. 20150921.